Published in

Wiley Open Access, CPT: Pharmacometrics and Systems Pharmacology, 6(4), p. 316-319, 2015

DOI: 10.1002/psp4.57

Links

Tools

Export citation

Search in Google Scholar

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

Journal article published in 2015 by Mj Swat, S. Moodie, Sm Wimalaratne ORCID, Nr Kristensen, M. Lavielle, A. Mari, P. Magni, Mk Smith, R. Bizzotto, L. Pasotti, E. Mezzalana, E. Comets, C. Sarr, N. Terranova, E. Blaudez and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

The lack of a common exchange format for mathematical models in pharmacometrics has been a long-standing problem. Such a format has the potential to increase productivity and analysis quality, simplify the handling of complex workflows, ensure reproducibility of research, and facilitate the reuse of existing model resources. Pharmacometrics Markup Language (PharmML), currently under development by the Drug Disease Model Resources (DDMoRe) consortium, is intended to become an exchange standard in pharmacometrics by providing means to encode models, trial designs, and modeling steps.